Catalog No.
EVV19906
Expression system
Mammalian Cells
Species
dengue virus type I
Protein length
Arg6-Gly385
Predicted molecular weight
49.71 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
A0A0N7E4Y2
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein
Structural basis for antibody cross-neutralization of dengue and Zika viruses., PMID:40502094
Flagellins as Vaccine Adjuvants and Cancer Immunotherapy: Recent Advances and Future Prospects., PMID:40491306
Multivalent administration of dengue E dimers on liposomes elicits type-specific neutralizing responses without immune interference., PMID:40490495
Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991
Development and validation of dengue virus envelope protein domain III IgG antibody enzyme-linked immunosorbent assay., PMID:40447073
Clinico-genomic study reveals association of dengue virus genome high frequency mutations with dengue disease severity., PMID:40436903
Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue., PMID:40432141
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity., PMID:40432061
Serologic Surveillance for Orthoflaviviruses and Chikungunya Virus in Bats and Opossums in Chiapas, Mexico., PMID:40431603
Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil., PMID:40400258
Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residue., PMID:40373693
Role of c-ABL in DENV-2 Infection and Actin Remodeling in Vero Cells., PMID:40362443
High Burden of Dengue and Chikungunya Virus in Paraguay: Seroprevalence Findings From Blood Donors., PMID:40358025
Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease., PMID:40333188
Evolution and adaptation of dengue virus in response to high-temperature passaging in mosquito cells., PMID:40330315
Genomic hotspots in the DENV-2 serotype (E, NS4B, and NS5 genes) are associated with dengue disease severity in the endemic region of India., PMID:40299925
Impact of dengue virus infection on the cytoadherence of Plasmodium vivax-infected erythrocytes., PMID:40298772
Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis., PMID:40288237
Modeling and Molecular Dynamics Studies of Flavone-DENV E-3 Protein-SWCNT Interaction at the Flavonoid Binding Sites., PMID:40284968
Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains., PMID:40237498
Proteins from Microalgae: Nutritional, Functional and Bioactive Properties., PMID:40231937
Toward a deeper understanding of dengue: novel method for quantification and isolation of envelope protein epitope-specific antibodies., PMID:40214258
Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa., PMID:40207881
Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity., PMID:40202994
In vitro and in vivo neutralization of Dengue virus by a single domain antibody., PMID:40180606
PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier., PMID:40170024
Comparative study on the utility of automated chemiluminescence immunoassay for NS1 antigen-based dengue diagnosis., PMID:40157587
Anellovirus abundance as an indicator for viral metagenomic classifier utility in plasma samples., PMID:40148934
Immune and vascular modulation by HERVs: the role of CXCR1 and IL18RAP in dengue severity progression., PMID:40124360
The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens., PMID:40102899
Ouratein D, a Biflavanone From Ouratea spectabilis, Alleviates Betacoronavirus Infection by Mitigating Inflammation, Lung Damage and Viral Replication., PMID:40099709
Dengue virus-host interactions: Structural and mechanistic insights for future therapeutic strategies., PMID:40090430
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak., PMID:40068726
Broad-spectrum antiviral ferruginol analog affects the viral proteins translation and actin remodeling during dengue virus infection., PMID:40043781
Darunavir inhibits dengue virus replication by targeting the hydrophobic pocket of the envelope protein., PMID:40024350
High correlation between detection of dengue IgG from dried blood spots and serum using an indirect IgG ELISA assay: A validation study in Fortaleza, Brazil., PMID:40019871
Elevated Plasma Angiopoietin-like 4 Protein Levels in Adult Patients with Dengue., PMID:40006981
Kinetics of NS1 and anti-NS1 IgG following dengue infection reveals likely early formation of immune complexes in secondary infected patients., PMID:39994315
Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains., PMID:39990303
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655
The zinc finger protein ZFP36L2 inhibits flavivirus infection via the 5'-3' XRN1-mediated RNA decay pathway in the replication complexes., PMID:39972499
Detection of viral antigen and inflammatory mediators in fatal pediatric dengue: a study on lung immunopathogenesis., PMID:39967674
RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262
Role of Cellular Mechanisms in Dengue Pathogenesis: Focus on Immune Cells Interactions., PMID:39936442
Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches., PMID:39905499
Functionalized cascaded tapered optical fiber sensor for simultaneous detection of dengue II E and SARS-CoV-2 S proteins., PMID:39904660
Domperidone inhibits dengue virus infection by targeting the viral envelope protein and nonstructural protein 1., PMID:39885306
Harnessing viral internal proteins to combat flu and beyond., PMID:39881469
Association of total and dengue-specific IgE levels in the sera with dengue virus inhibition and antibody-dependent enhancement., PMID:39876506
Optimization of Conditions for Expression of Dengue Serotype 2 EDIII Protein in Escherichia coli and Immune Responses of Adjuvant-Free EDIII Ferritin Nanoparticles Against Dengue Virus in BALB/c Mice., PMID:39861918
For research use only. Not for human or drug use.
